Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INVITAE CORPORATION

(NVTA)
  Report
Delayed Nyse  -  04:00 2022-09-28 pm EDT
2.620 USD   +11.02%
09/27Invitae Appointed to National Quality Forum Committee on Quality Standards for Healthcare
PR
09/20Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing
AQ
09/20Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/22/2022 09/23/2022 09/26/2022 09/27/2022 09/28/2022 Date
2.56(c) 2.44(c) 2.41(c) 2.36(c) 2.62(c) Last
10 318 687 6 403 947 8 760 614 7 832 250 19 305 168 Volume
-7.58% -4.69% -1.23% -2.07% +11.02% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 517 M - -
Net income 2022 -3 094 M - -
Net Debt 2022 1 333 M - -
P/E ratio 2022 -0,20x
Yield 2022 -
Sales 2023 523 M - -
Net income 2023 -528 M - -
Net Debt 2023 1 355 M - -
P/E ratio 2023 -1,21x
Yield 2023 -
Capitalization 616 M 616 M -
EV / Sales 2022 3,77x
EV / Sales 2023 3,77x
Nbr of Employees 3 000
Free-Float 99,0%
More Financials
Company
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other... 
More about the company
Ratings of Invitae Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about INVITAE CORPORATION
09/27Invitae Appointed to National Quality Forum Committee on Quality Standards for Healthca..
PR
09/20Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND..
AQ
09/20Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND..
CI
09/15Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for..
PR
09/13Transcript : Invitae Corporation Presents at Morgan Stanley 20th Annual Globa..
CI
09/12Invitae and Simons Searchlight Partner to Accelerate Research through Data Sharing
PR
09/12Invitae and Simons Searchlight Partners to Accelerate Research Through Data Sharing
CI
08/30Invitae to Present at Upcoming Investor Conference
PR
08/25Invitae Corp : Change in Directors or Principal Officers (form 8-K)
AQ
08/25Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagn..
MT
08/18Insider Sell: Invitae
MT
08/11Top Premarket Decliners
MT
08/10Sector Update: Health Care Stocks Set to Finish Moderately Higher
MT
08/10Sector Update: Health Care Stocks Carried Higher with Broader Markets
MT
08/10Sector Update: Health Care
MT
More news
News in other languages on INVITAE CORPORATION
09/20Les données sur les citoyens en situation réelle d'Invitae sont utilisées dans le dossi..
09/12Invitae et Simons Searchlight s'associent pour accélérer la recherche grâce au partage ..
08/18Vente d'initiés : Invitae
08/10Mise à jour sectorielle : Les actions du secteur de la santé dev..
08/10Mise à jour sectorielle : Les actions du secteur de la santé ont..
More news
Analyst Recommendations on INVITAE CORPORATION
More recommendations
ETFs positioned on INVITAE CORPORATIONETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
CI Bio-Revolution ETF - CAD1.34%0.00%-NC
Global X Genomics & Biotechnology ETF - USD1.3%-0.46%NC
SPDR S&P Health Care Services ETF - USD1.15%-5.14%United_States
IShares Genomics Immunology and Healthcare ...0.94%-6.74%World
Global X Telemedicine & Digital Health ETF - USD0.83%-1.37%-NC
More ETFs positioned on INVITAE CORPORATION
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 2,62 $
Average target price 2,71 $
Spread / Average Target 3,37%
EPS Revisions
Managers and Directors
Kenneth D. Knight Chief Executive Officer & Director
Roxi Wen Chief Financial Officer
Randy W. Scott Director
Robert L. Nussbaum Chief Medical Officer
Eric Olivares Chief Science Officer
Sector and Competitors